PHARMA AND MEDICAL BIOTECHNOLOGY - Business Tampere
Skip to content

Tampere offers excellent opportunities for pharmaceutical research and medical biotechnology

Tampere has very strong research capabilities for cardiovascular diseases, vaccines, celiac disease, oncology and pediatric diseases. Bioinformatics and clinical informatics provide new opportunities for health technology.

Tampere University Hospital offers excellent conditions for clinical research, which is supported by the Finnish Clinical Biobank Tampere (FCBT). FCBT is the fastest growing biobank in Finland and it is developing new methods for instance using cold chain robotics in the sample handling.

As an example, Santen, a world leading Ophthalmology company, has a major R&D unit in Tampere. In biotechnology, Tampere  is particularly strong in the fields of tissue engineering and stem cell therapy. The prime example being a bone graft cultured from stem cells isolated from patient’s own tissue and grown inside his abdomen.

Tampere University Hospital

Tampere University Hospital Tays is a visionary healthcare provider. In addition to excellent care the focus is on research, development and innovation. As a university hospital it educates the future healthcare professionals.

Tampere University Community and Research Centers

Tampere University community’s priority areas are technology, health and society. The faculty of Medicine and Health Technology is committed to generating new knowledge and solutions that promote health and wellbeing and benefit both individuals and the broader society. With staff of over 500 with over 70 research groups, it brings together unique research expertise in medicine, biosciences, and engineering,

Startup Tampere support for startups in COVID-19 situation

Startup Team at Business Tampere does its best to organize services online, respond on new rising needs and combine information on one place. We have gathered in this news shortly the most important things about existing services and changes in the situation.
Back to top